The acquisition of Amira Pharmaceuticals by Bristol-Myers Squibb was completed on September 7, 2011. For more information please visit www.bms.com. For matters related to FLAP or DP2, please refer to www.panmira.com

 

  
   

9535 Waples Street, Suite 100
San Diego, CA 92121

Phone: (858) 228-4650
Fax: (858) 558-8979

Media

Jennifer Fron Mauer
609-252-6579
jennifer.mauer@bms.com  

 

21-July-2011:
Bristol-Myers Squibb Company (NYSE:BMY) and Amira Pharmaceuticals, Inc., announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. <more>

 

 

© Copyright Amira Pharmaceuticals 2005-2011. All rights reserved